These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues. Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931 [TBL] [Abstract][Full Text] [Related]
28. [Local lipohypertrophy in insulin treatment]. Herold DA; Albrecht G Hautarzt; 1993 Jan; 44(1):40-2. PubMed ID: 8436508 [TBL] [Abstract][Full Text] [Related]
29. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study. Hermansen K; Dornhorst A; Sreenan S Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940 [TBL] [Abstract][Full Text] [Related]
30. Eva Kasierer: 72-year-old pumper. At age 72, Eva Kasierer mastered the insulin pump and now enjoys better diabetes control than ever. Mazur ML Diabetes Forecast; 2002 Apr; 55(4):45-7. PubMed ID: 14964146 [No Abstract] [Full Text] [Related]
31. Are insulin pumps underutilized in type 1 diabetes? No. Schade DS; Valentine V Diabetes Care; 2006 Jun; 29(6):1453-5. PubMed ID: 16732044 [No Abstract] [Full Text] [Related]
32. Insulin infusion pumps: new solution to an old problem. Childs BP Nursing; 1983 Nov; 13(11):54-7. PubMed ID: 6355927 [No Abstract] [Full Text] [Related]
33. For parents. To pump, or not to pump? Butler D Diabetes Self Manag; 2005; 22(5):74-6, 78, 80. PubMed ID: 16220598 [No Abstract] [Full Text] [Related]
34. [Evaluating the feature of hypoglycemia detected by continuous glucose monitoring system during temporary continuous subcutaneous insulin infusion in type 2 diabetes patients]. Li M; Zhou J; Bo YQ; Lu W; Jia WP; Xiang KS Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1679-82. PubMed ID: 19024537 [TBL] [Abstract][Full Text] [Related]
36. Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose control. Radermecker RP; Renard E; Scheen AJ Diabetes Metab Res Rev; 2009 Sep; 25(6):491-501. PubMed ID: 19496088 [TBL] [Abstract][Full Text] [Related]
37. Insulin requirement in preschoolers treated with insulin pumps at the onset of type 1 diabetes mellitus. Szypowska A; Lipka M; Błazik M; Groele L; Pańkowska E Acta Paediatr; 2009 Mar; 98(3):527-30. PubMed ID: 19021593 [TBL] [Abstract][Full Text] [Related]
38. Gelling of insulin within an insulin pump reservoir. Blumer I Diabet Med; 2008 Sep; 25(9):1131. PubMed ID: 18937680 [No Abstract] [Full Text] [Related]
39. Type 1 diabetes mellitus: effective insulin strategies with less hypoglycemia. Bolli GB Postgrad Med; 2004 Nov; 116(5 Suppl Exploring):13-20. PubMed ID: 19667675 [TBL] [Abstract][Full Text] [Related]
40. Benefits of a bolus calculator in pre- and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII). Shashaj B; Busetto E; Sulli N Diabet Med; 2008 Sep; 25(9):1036-42. PubMed ID: 18937673 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]